申请人:SmithKline Beecham Corporation
公开号:US05684032A1
公开(公告)日:1997-11-04
This invention relates to novel carboxylic acid indole compounds and compositions for use in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
这项发明涉及新型的羧酸吲哚化合物和用于治疗由趋化因子白细胞介素-8(IL-8)介导的疾病状态的组合物。